Scarica l'app Stockscreener
64.02
3.56%
2.20
Dopo l'orario di chiusura:
64.00
-0.02
-0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$61.82
Aprire:
$62
Volume 24 ore:
1.77M
Relative Volume:
0.74
Capitalizzazione di mercato:
$8.76B
Reddito:
$550.17M
Utile/perdita netta:
$201.35M
Rapporto P/E:
64.02
EPS:
1
Flusso di cassa netto:
$232.07M
1 W Prestazione:
+10.13%
1M Prestazione:
+6.35%
6M Prestazione:
-16.85%
1 anno Prestazione:
+79.93%
Intervallo 1D:
$61.88
$64.73
Intervallo di 1 settimana:
$57.46
$66.80
Portata 52W:
$34.34
$85.21
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Confronta DOCS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
89.27 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
191,798 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by AGF Management Ltd. - MarketBeat
Doximity (NASDAQ:DOCS) Stock Price Expected to Rise, Raymond James Financial Analyst Says - MarketBeat
LPL Financial LLC Purchases 31,468 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity buys AI clinical reference startup Pathway for $63 million - DOTmed
Doximity’s Earnings Call Highlights Growth and AI Advances - TipRanks
Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Call Transcript - MSN
Doximity (NASDAQ:DOCS) Trading Down 6.5% on Insider Selling - MarketBeat
Doximity rises on Q1 beat; buys Canadian AI-based clinical reference firm - MSN
Jefferies Financial Group Inc. Sells 13,195 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Insider Selling: Doximity, Inc. (NASDAQ:DOCS) Director Sells 5,000 Shares of Stock - MarketBeat
Doximity acquires AI-powered clinical decision support tool - TechTarget
Doximity (NASDAQ:DOCS) Price Target Raised to $69.00 at Piper Sandler - MarketBeat
Doximity Buying Pathway In $63 Million Deal - Pulse 2.0
DOCS Q2 Deep Dive: AI Investment, Product Expansion, and Broad-Based Customer Momentum - TradingView
What makes Doximity Inc. stock price move sharplyOversold Recovery Picks - thegnnews.com
Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by Natixis Advisors LLC - MarketBeat
Analysts Weigh In on Green Thumb Industries, Doximity, and BioLife Solutions - AInvest
Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN
Doximity Plummets 6.4%: What's Fueling the Selloff? - AInvest
Doximity (NASDAQ:DOCS) Announces Earnings Results - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Blair William & Co. IL - MarketBeat
Bank of Nova Scotia Makes New Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (DOCS) Is Up 14.2% After AI Acquisition and Revenue BeatWhat's Changed - simplywall.st
Canaccord Genuity Group Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) Stock - MarketBeat
Sierra Summit Advisors LLC Makes New Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Doximity outlines 11% full-year revenue growth target as AI suite and Pathway acquisition accelerate platform expansion - MSN
Doximity (NASDAQ:DOCS) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Doximity (NASDAQ:DOCS) Price Target Raised to $75.00 at Needham & Company LLC - MarketBeat
Doximity First Quarter 2026 Earnings: Beats Expectations - Yahoo Finance
Doximity Shares Surge as Strategic Moves and Strong Earnings Impress Investors - timothysykes.com
10 Stocks with Eye-Popping Gains; 5 Jump to New Highs - Insider Monkey
Mackenzie Financial Corp Cuts Stock Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
U.S. Indexes Rose Friday; Doximity Topped Leaders - Barron's
Why Doximity's Recent Earnings and Guidance Signal a Buy Opportunity for Long-Term Growth - AInvest
Doximity stock price target raised to $69 by Piper Sandler on AI innovation - Investing.com South Africa
Why Is Doximity (DOCS) Stock Rocketing Higher Today - Yahoo Finance
DOCS Stock Surges: What’s Driving the Rise? - StocksToTrade
Doximity shares rise 11.78% intraday after acquiring Pathway Medical, a leader in AI clinical reference. - AInvest
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down - The Globe and Mail
Truist Securities Adjusts Price Target on Doximity to $62 From $61, Maintains Hold Rating - MarketScreener
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings - Benzinga
SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday - Benzinga
Doximity (DOCS) Surges 11% Intraday: AI Acquisition Ignites Bullish Momentum Amid Record Revenue Growth - AInvest
Earnings call transcript: Doximity beats Q1 2026 expectations, stock surges - Investing.com India
Doximity Surges on Q1 Beat, Acquires Canadian AI Firm Pathway Medical - AInvest
Doximity stock rises on Q1 beat; AI acqusition (DOCS:NYSE) - Seeking Alpha
Earnings call transcript: Doximity beats Q1 2026 expectations, stock surges By Investing.com - Investing.com UK
Pinterest To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Leerink Partners raises Doximity stock price target to $79 on strong results - Investing.com Australia
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by TD Asset Management Inc - MarketBeat
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.99%
2.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):